Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Herrett, A. M. Gallagher, K. Bhaskaran, H. Forbes, R. Mathur, T. Staa, L. Smeeth (2015)
Data resource profile: Clinical practice research datalink (CPRD), 44
Y. Qian, S. Maruyama, H. Kim, E. L. Pollom, K. A. Kumar, A. L. Chin, J. P. Harris, D. T. Chang, A. Pitt, E. Bendavid, D. K. Owens, B. Y. Durkee, S. G. Soltys (2017)
Cost‐effectiveness of radiation and chemotherapy for high‐risk low‐grade glioma, 19
A. Waschke, H. Arefian, J. Walter, M. Hartmann, J. Maschmann, R. Kalff (2018)
Cost‐effectiveness of the long‐term use of temozolomide for treating newly diagnosed glioblastoma in Germany, 138
K. Zienius, I. P. Chak‐Lam, J. Park, M. Ozawa, W. Hamilton, D. Weller, D. Summers, L. Porteous, S. Mohiuddin, E. Keeney, W. Hollingworth, Y. Ben‐Shlomo, R. Grant, P. M. Brennan (2019)
Direct access CT for suspicion of brain tumour: an analysis of referral pathways in a population‐based patient group, 20
R. Smith‐Bindman, J. Lipson, R. Marcus, K. P. Kim, M. Mahesh, R. Gould, A. Berrington de González, D. L. Miglioretti (2009)
Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer, 169
R. D. Neal, P. Tharmanathan, B. France, N. U. Din, S. Cotton, J. Fallon‐Ferguson, W. Hamilton, A. Hendry, M. Hendry, R. Lewis, U. Macleod, E. D. Mitchell, M. Pickett, T. Rai, K. Shaw, N. Stuart, M. L. Tørring, C. Wilkinson, B. Williams, J. Emery (2015)
Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review, 112
C. E. Clarke, J. Edwards, D. J. Nicholl, A. Sivaguru (2010)
Imaging results in a consecutive series of 530 new patients in the Birmingham Headache Service, 8
L. B. A. Curtis (2016)
Unit costs of health and social care 2016
(2017)
United Kingdom, national life tables, 1980–82 to 2014–16
(2018)
Brain, other CNS and intracranial tumours statistics
(2018)
July 2018: monthly exchange rates
Y. Narita, S. Shibui (2015)
Trends and outcomes in the treatment of gliomas based on data during 2001–2004 from the Brain Tumor Registry of Japan, 55
E. Gray, H. J. Butler, R. Board, P. M. Brennan, A. J. Chalmers, T. Dawson, J. Goodden, W. Hamilton, M. G. Hegarty, A. James, M. D. Jenkinson, D. Kernick, E. Lekka, L. J. Livermore, S. J. Mills, K. O’Neill, D. S. Palmer, B. Vaqas, M. J. Baker (2018)
Health economic evaluation of a serum‐based blood test for brain tumour diagnosis: exploration of two clinical scenarios, 8
D. P. Kernick, F. Ahmed, A. Bahra, A. Dowson, G. Elrington, M. Fontebasso, N. J. Giffin, S. Lipscombe, A. MacGregor, R. Peatfield, S. Weatherby, T. Whitmarsh, P. J. Goadsby (2008)
Imaging patients with suspected brain tumour: guidance for primary care, 58
H. M. Treasury (2018)
GDP deflators at market prices, and money GDP March 2018 (Quarterly National Accounts)
G. C. Simpson, K. Forbes, E. Teasdale, A. Tyagi, C. Santosh (2010)
Impact of GP direct‐access computerised tomography for the investigation of chronic daily headache, 60
A. Brodbelt, D. Greenberg, T. Winters, M. Williams, S. Vernon, V. P. Collins (2015)
Glioblastoma in England: 2007–2011, 51
(2015)
Suspected cancer: recognition and referral
E. Vera, A. A. Acquaye, T. R. Mendoza, M. R. Gilbert, T. S. Armstrong (2018)
Relationship between symptom burden and health status: analysis of the MDASI‐BT and EQ‐5D, 5
C. De Oliveira, R. Pataky, K. Bremner, J. Rangrej, K. Chan, W. Cheung, J. Hoch, S. Peacock, M. Krahn (2017)
Estimating the cost of cancer care in British Columbia and Ontario: A Canadian inter‐provincial comparison, 12
(2016)
NHS reference costs 2015/16
R. Garside, M. Pitt, R. Anderson, G. Rogers, M. Dyer, S. Mealing, M. Somerville, A. Price, K. Stein (2007)
The effectiveness and cost‐effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high‐grade glioma: a systematic review and economic evaluation, 11
J. A. Miller, R. Kotecha, G. H. Barnett, J. H. Suh, L. Angelov, E. S. Murphy, M. A. Vogelbaum, A. Mohammadi, S. T. Chao (2017)
Quality of life following stereotactic radiosurgery for single and multiple brain metastases, 81
T. E. Locker, C. Thompson, J. Rylance, S. M. Mason (2006)
The Utility of clinical features in patients presenting with nontraumatic headache: An investigation of adult patients attending an emergency department, 46
M. Ozawa, P. M. Brennan, K. Zienius, K. M. Kurian, W. Hollingworth, D. Weller, W. Hamilton, R. Grant, Y. Ben‐Shlomo (2018)
Symptoms in primary care with time to diagnosis of brain tumours, 35
B. D. Nicholson, J. L. Oke, P. W. Rose, D. Mant (2016)
Variation in direct access to tests to investigate cancer: A survey of English general practitioners, 11
W. Stummer, U. Pichlmeier, T. Meinel, O. D. Wiestler, F. Zanella, H.‐J. Reulen (2006)
Fluorescence‐guided surgery with 5‐aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial, 7
L. Elliss‐Brookes, S. McPhail, A. Ives, M. Greenslade, J. Shelton, S. Hiom, M. Richards (2012)
Routes to diagnosis for cancer – determining the patient journey using multiple routine data sets, 107
L. Howard, S. Wessely, M. Leese, L. Page, P. McCrone, K. Husain, J. Tong, A. Dowson (2005)
Are investigations anxiolytic or anxiogenic? A randomised controlled trial of neuroimaging to provide reassurance in chronic daily headache, 76
A. Briggs, M. Sculpher, K. Claxton (2006)
Decision modelling for health economic evaluation
P. W. Sperduto, N. Kased, D. Roberge, Z. Xu, R. Shanley, X. Luo, P. K. Sneed, S. T. Chao, R. J. Weil, J. Suh, A. Bhatt, A. W. Jensen, P. D. Brown, H. A. Shih, J. Kirkpatrick, L. E. Gaspar, J. B. Fiveash, V. Chiang, J. P. S. Knisely, M. Mehta (2012)
Summary report on the graded prognostic assessment: an accurate and facile diagnosis‐specific tool to estimate survival for patients with brain metastases, 30
(2013)
Guide to the methods of technology appraisal
M. C. Weinstein, G. Torrance, A. McGuire (2009)
QALYs: The basics, 12
R. Swann, S. McPhail, J. Witt, B. Shand, G. A. Abel, S. Hiom, J. Rashbass, G. Lyratzopoulos, G. Rubin (2018)
Diagnosing cancer in primary care: Results from the National Cancer Diagnosis Audit, 68
European Journal of Cancer Care – Wiley
Published: Jan 1, 2021
Keywords: ; ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.